PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,765,000 | -23.6% | 1,392,997 | 0.0% | 0.59% | -16.5% |
| Q2 2021 | $12,788,000 | -5.6% | 1,392,997 | 0.0% | 0.70% | -8.6% |
| Q1 2021 | $13,540,000 | -3.9% | 1,392,997 | +1.4% | 0.77% | +4.3% |
| Q4 2020 | $14,096,000 | +2.1% | 1,373,897 | +0.4% | 0.74% | -2.5% |
| Q3 2020 | $13,806,000 | -1.5% | 1,368,317 | +1.8% | 0.76% | -10.0% |
| Q2 2020 | $14,017,000 | +18.9% | 1,343,897 | -3.7% | 0.84% | -14.7% |
| Q1 2020 | $11,784,000 | -0.2% | 1,396,163 | +3.5% | 0.99% | +51.8% |
| Q4 2019 | $11,805,000 | -22.0% | 1,349,180 | -4.0% | 0.65% | -35.5% |
| Q3 2019 | $15,132,000 | -15.3% | 1,405,680 | 0.0% | 1.01% | +16.0% |
| Q2 2019 | $17,866,000 | -61.0% | 1,405,680 | +19.0% | 0.87% | -54.5% |
| Q1 2019 | $45,802,000 | +94.0% | 1,180,780 | +1.8% | 1.91% | +52.0% |
| Q4 2018 | $23,604,000 | – | 1,159,900 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |